Presence of human prolactin-producing adenomas and bromocriptine: A histological, immunocytochemical, ultrastructural, and morphometric study

Journal of Clinical Endocrinology and Metabolism

Volumn 55, Issue 6, 1982, Pages 1178-1183

  Tindall, George T ^a   Kovacs, Kalman ^a,b   Horvath, Eva ^a,b   Thorner, Michael O ^a,c  

^a EMORY CLINIC   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE;

AMENORRHEA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSIS; DRUG THERAPY; ELECTRON MICROSCOPY; ENDOCRINE SYSTEM; HISTOLOGY; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOCYTOCHEMISTRY; MORPHOMETRICS; PROLACTINOMA; THERAPY; ULTRASTRUCTURE;

ADENOMA; ADOLESCENT; ADULT; BROMOCRIPTINE; FEMALE; HISTOCYTOCHEMISTRY; HUMAN; IMMUNOENZYME TECHNIQUES; MALE; MICROSCOPY, ELECTRON; MIDDLE AGE; PITUITARY NEOPLASMS; PROLACTIN; RADIOIMMUNOASSAY; SUPPORT, NON-U.S. GOV'T;

EID: 0020366879     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-55-6-1178     Document Type: Article

References (26)

1. Thorner MO, Evans WS, MacLeod RM, Nunley Jr WC, Rogol AD, Morris JL, Besser GM 1980 Hyperprolactinemia: Current concepts of management including medical therapy with bromocriptine. In: Golstein M, Caine DB, Lieberman A, Thorner MO (eds) Advances in Biochemical Psychoparmacology. Raven Press, New York, vol 23: 165
2. Kleinberg DL, Noel GL, Frantz AG 1977 Galactorrhea: 235 cases including 48 with pituitary tumors. N Engl J Med 296: 589
3. MacGregor AM, Scanlon MF, Hall R, Hall K 1979 Effects of bromocriptine on pituitary tumor size. Br Med J 2: 700
4. Thorner MO, Martin WH, Rogol AD, Morris JL, Perryman RL, Conway BP, Howards SS, Wolfman MG, MacLeod RM 1980 Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab 51: 438
5. Chiodini P, Liuzzi A, Cozzi R, Verde G, Oppizzi G, Dallabonzana D, Spelta B, Silvestrini F, Borghi G, Luccarelli G, Rainer E, Horowski R 1981 Size reduction of macroprolactinomas by bromocriptine or lisuride treatment. J Clin Endocrinol Metab 52: 737
6. Thorner MO, Perryman RL, Rogol AD, Conway BP, MacLeod RM, Login IS, Morris JL 1981 Rapid changes of prolactinoma volume following withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab 53: 480
7. Tindall GT, McLanahan S, Christy JH 1978 Transsphenoidal microsurgery for pituitary tumors associated with hyperprolactinemia. J Neurosurg 48: 846
8. Kovacs K, Horvath E, Ryan N 1981 Immunocytology of the human pituitary. In: Delellis RA (ed) Diagnostic Immunohistochemistry. Masson, New York, p 17
9. McComb DJ, Kovacs K 1978 Ultrastructural morphometry of sparsely granulated prolactin cell adenomas of the human pituitary. Acta Endocrinol (Copenh) 89: 521
10. Kovacs K, Horvath E, Ezrin C 1977 Pituitary adenomas. Pathol Ann 12: 341
11. Corenblum B, Webster BR, Mortimer CB, Ezrin C 1975 Possible anti-tumor effect of 2-bromo-ergocryptine (CB-154, Sandoz) in two patients with large prolactin secreting pituitary adenomas. Clin Res 23: 614A
12. Davies C, Jacobi J, Lloyd HM, Meares JD 1974 DNA synthesis and secretion of prolactin and growth hormone by the pituitary gland of the male rat: Effects of diethyl stilboestrol and 2-brom-alpha-ergokryptine methanesulphonate. J Endocrinol 61: 411
13. Lloyd HM, Meares JD, Jacobi J 1975 Effects of estrogen and bromocriptine in in vivo secretion and mitosis in prolactin cells. Nature 255: 497
14. Rengachary SS, Tomita T, Jefferies BF, Watanabe I 1982 Structural changes in human pituitary tumor after bromocriptine therapy. Neurosurgery 10: 242
15. Cronin MJ, Roberts JM, Weiner RI 1978 Dopamine and dihydroer-gocryptine binding to the anterior pituitary and other brain areas of the rat and sheep. Endocrinology 103: 302
16. Meltzer HY, So R, Miller RJ Fang VS 1979 Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spiroperidol in the rat pituitary and striatum with in vivo effects on rat prolactin secretion. Life Sci 25: 573
17. Stefanini E, Clement-Cormier Y, Vernalone F, Devoto P, Marchisio AM, Collu R 1981 Sodium-dependent interaction of benzamides with dopamine receptors in rat and dog anterior pituitary gland. Neuroendocrinology 32: 103
18. Bression D, Brandi AM, Martres MP, Nousbaum A, Cesselin F, Peillon F 1980 Dopaminergic receptors in human prolactin-secreting adenomas: A quantitative study. J Clin Endocrinol Metab 51: 1037
19. Cronin MJ, Cheung CY, Wilson CB, Jaffe RB, Weiner RJ 1980 3H-Spiperone binding to human anterior pituitaries and pituitary adenomas secreting prolactin, growth hormone and adrenocorticotropic hormone. J Clin Endocrinol Metab 50: 387
20. Cronin MJ 1982 The role and direct measurement of the dopamine receptor(s) of the anterior pituitary. In: Macleod RM, Müller EE (eds) Neuroendocrine Perspectives. Elsevier, Amsterdam, vol 1: 167
21. Thorner MO, Hackett JT, Murad F, MacLeod RM 1980 Calcium rather than cyclic AMP as the intracellular regulator of prolactin release. Neuroendocrinology 31: 390
22. MacLeod RM, Cronin MJ, Valdenegro CA, Login IS, Thorner MO 1980 Neural and ovarian regulation of prolactin production. In: Brambella F, Racagni C, de Weid D (eds) Progress in Psychoneuroendocrinology. Elsevier/North Holland Press, Amsterdam, p 63
23. Maurer RA 1980 Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells. J Biol Chem 255: 8092
24. Tam SW, Dannies PS 1980 Dopaminergic inhibition of ionophore A 23187-stimulated release of prolactin from rat anterior pituitary cells. J Biol Chem 255: 6595
25. Giannattasio G, De Ferkari ME, Spada A 1981 Dopamine-inhibited adenylate cyclase in female rat adenohypophysis. Life Sci 28: 1605
26. Canonico PL, Valdenegro CA, MacLeod RM 1982 Dopamine inhibits 32Pi incorporation in phosphatidylinositol in the anterior pituitary of the rat. Endocrinology 111: 347